Schedule 13G ownership disclosure

Puramed Bioscience Inc.

Security class unavailable · CUSIP: 746094101

Event date: 2014-12-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
21,543,501
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-072720
Form type
SC 13G/A
Filer
Magna Management, LLC
CIK
CIK 1557712
Filed
Dec 08, 2014
Reporting period
Dec 05, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub